BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34451400)

  • 1. SARS-CoV-2 Infection and Guillain-Barré Syndrome.
    Makhluf H; Madany H
    Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.
    Shoraka S; Ferreira MLB; Mohebbi SR; Ghaemi A
    Front Immunol; 2021; 12():674922. PubMed ID: 34040615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
    Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
    J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barre syndrome and pulmonary embolism in an adult female with COVID-19 infection in Ghana: A case report.
    Tetteh-Wayoe E; Duodu F; Pekyi-Boateng PK; Agyeman Badu NB; Akpalu A; Adjei P
    Medicine (Baltimore); 2023 May; 102(20):e33754. PubMed ID: 37335689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
    Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
    J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19-induced Guillain-Barre Syndrome: A Rare Complication of SARS-CoV-2 Infection.
    Hanif M; Khan AW; Khan MA; Sundas F; Khan SJ
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):S123-S124. PubMed ID: 34271810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome.
    Galassi G; Marchioni A
    Acta Neurol Belg; 2020 Oct; 120(5):1067-1075. PubMed ID: 32696312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
    Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
    Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barre syndrome following subclinical COVID-19 infection in a child.
    Parikh C; Patel S; Shah J; Tandon R; Jetha K
    J Family Med Prim Care; 2022 Jun; 11(6):3333-3335. PubMed ID: 36119325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report.
    Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO
    J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two case reports and a literature review of typical GBS and rare GBS variants associated with COVID-19.
    Orak SA; Kubur ÇÇ; Atasever AK; Polat M
    Arch Pediatr; 2023 May; 30(4):236-239. PubMed ID: 37069023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bifacial weakness with paresthesia – a rare Guillain–Barré syndrome subtype associated with SARS-CoV-2 infection].
    Gaál T; Szeszák G; Torák G; Salacz P
    Orv Hetil; 2021 Nov; 162(45):1803-1807. PubMed ID: 34747359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré Syndrome Associated with SARS CoV-2 Infection: Case Report.
    Nigatu D; Tigabu T; Awraris M; Yohannes A; Kebede D
    Ethiop J Health Sci; 2022 Jan; 32(1):205-208. PubMed ID: 35250231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine.
    Waheed S; Bayas A; Hindi F; Rizvi Z; Espinosa PS
    Cureus; 2021 Feb; 13(2):e13426. PubMed ID: 33758714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barre Syndrome in a Patient With COVID-19 Infection.
    Sidhom F; Sandhu H
    Cureus; 2021 Aug; 13(8):e17052. PubMed ID: 34522530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of covid-19 and Guillain-Barré syndrome: A Mechanistic Perspective.
    Sharma V; Chhabra T; Singh TG
    Obes Med; 2023 Jun; 40():100493. PubMed ID: 37131407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.